Page last updated: 2024-10-19

niacinamide and Left Ventricular Hypertrophy

niacinamide has been researched along with Left Ventricular Hypertrophy in 2 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daryadel, A1
Bogdanova, A1
Gassmann, M1
Mueller, X1
Zünd, G1
Seifert, B1
Lehalle, C1
Frossard, N1
Tavakoli, R1
Alcendor, RR1
Kirshenbaum, LA1
Imai, S1
Vatner, SF1
Sadoshima, J1

Other Studies

2 other studies available for niacinamide and Left Ventricular Hypertrophy

ArticleYear
Multikinase inhibitor sorafenib prevents pressure overload-induced left ventricular hypertrophy in rats by blocking the c-Raf/ERK1/2 signaling pathway.
    Journal of cardiothoracic surgery, 2014, May-09, Volume: 9

    Topics: Animals; Becaplermin; Blood Pressure; Blotting, Western; Disease Models, Animal; Enzyme-Linked Immun

2014
Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
    Circulation research, 2004, Nov-12, Volume: 95, Issue:10

    Topics: Acetylation; Alkaloids; Animals; Apoptosis; Atrial Natriuretic Factor; Benzamides; Benzophenanthridi

2004